STOCK TITAN

Palomar Holdings, Inc. (PLMR) Financials

PLMR
Trailing 12 months to June 30, 2026
Revenue $1.1B +60.0% YoY
Net Income $203.2M +31.1% YoY
EPS (Diluted) $7.43 +30.6% YoY
Free Cash Flow $414.8M +9.0% YoY
Market Cap $3.4B as of Oct 10, 2026
Price / Sales 3.2x on $1.1B revenue, trailing 12 months to June 30, 2026
Price / Earnings 16.9x on $203.2M net income, trailing 12 months to June 30, 2026
Price / Book 3.5x on $980.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PLMR SEC filings page.

Palomar Holdings, Inc. (PLMR) reported $1.1B in revenue over the twelve months to Jun 30, 2026, up 60.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PLMR FY2025

Palomar’s business is expanding rapidly while converting earnings into cash, with growth funded more by balance-sheet liabilities than by fixed-asset spending.

Cash conversion is unusually close: FY2025 operating cash flow of $409M nearly matched net income of $197M plus non-cash and working-capital effects, while free cash flow reached $409M because capital expenditures were only $137K. That combination suggests reported earnings are translating into cash without heavy reinvestment in physical assets, even as investing outflows remain substantial.

Margin expansion accompanied scale: revenue increased from $376M in FY2023 to $876M in FY2025, while net margin moved from 21.1% to 22.5%. Profit therefore grew faster than revenue, indicating that additional volume was not merely offset by proportionate costs.

The balance sheet is growing faster than equity: total assets rose to $3.1B in FY2025 from $1.7B in FY2023, while liabilities reached $2.1B and equity reached $943M. The reported debt-to-equity ratio fell to 0.0x alongside zero long-term debt, so the leverage shown here is carried mainly through liabilities other than reported long-term borrowing.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Loss Ratio PremiumGrowth Capital Investment Yield CombinedRatio Stability 67 / 100
Financial Health Score 67/100
Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Palomar Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio
90

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Palomar Holdings, Inc. scores 90/100 on it among other insurers.

Premium Growth
97

Palomar Holdings, Inc. reported revenue of $876.0M in fiscal year 2025, against $553.9M in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Palomar Holdings, Inc. scores 97/100 among other insurers.

Capital
70

Palomar Holdings, Inc. funded 30.9% of its assets with shareholders' equity at the end of fiscal year 2025, holding $942.7M of equity against $3.1B of assets. Capital ranks insurers on that cushion, and Palomar Holdings, Inc. scores 70/100 among other insurers.

Investment Yield
0

Not available for Palomar Holdings, Inc., and counted as zero in the overall score.

Combined Ratio
90

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Palomar Holdings, Inc. scores 90/100 on it among other insurers.

Stability
55

Palomar Holdings, Inc. reported net income of $197.1M in fiscal year 2025, against $117.6M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Palomar Holdings, Inc. scores 55/100 among other insurers.

Piotroski F-Score Partial
5/6

Palomar Holdings, Inc. passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
2.08x

For every $1 of reported earnings, Palomar Holdings, Inc. generates $2.08 in operating cash flow ($409.1M OCF vs $197.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$314.4M
YoY+54.7%
QoQ+12.7%
5Y CAGR+40.4%

Palomar Holdings, Inc. generated $314.4M in revenue in Q2 2026. This represents an increase of 54.7% from the same quarter a year earlier. Against the prior quarter it is up 12.7%.

Net Income
$52.6M
YoY+13.0%
QoQ+22.5%
5Y CAGR+33.6%

Palomar Holdings, Inc. reported $52.6M in net income in Q2 2026. This represents an increase of 13.0% from the same quarter a year earlier. Against the prior quarter it is up 22.5%.

EPS (Diluted)
$1.94
YoY+15.5%
QoQ+23.6%
5Y CAGR+32.8%

Palomar Holdings, Inc. earned $1.94 per diluted share (EPS) in Q2 2026. This represents an increase of 15.5% from the same quarter a year earlier. Against the prior quarter it is up 23.6%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$166.8M
YoY+38.0%
QoQ+254.6%

Palomar Holdings, Inc. generated $166.8M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 38.0% from the same quarter a year earlier. Against the prior quarter it is up 254.6%.

Cash & Debt
$62.7M
YoY-22.9%
QoQ+10.9%
5Y CAGR+20.3%

Palomar Holdings, Inc. held $62.7M in cash against $295.8M in long-term debt as of Q2 2026.

Shares Outstanding
26M
YoY-1.7%
QoQ-0.7%
5Y CAGR+0.7%

Palomar Holdings, Inc. had 26M shares outstanding in Q2 2026. This represents a decrease of 1.7% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin
16.7%
YoY-6.2pp
QoQ+1.3pp
5Y change-4.6pp

Palomar Holdings, Inc.'s net profit margin was 16.7% in Q2 2026, showing the share of revenue converted to profit. This is down 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Return on Equity
5.4%
YoY-0.1pp
QoQ+0.9pp
5Y change+2.1pp

Palomar Holdings, Inc.'s ROE was 5.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$41.0M
QoQ+77.7%

Palomar Holdings, Inc. spent $41.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 77.7%.

Capital Expenditures
$416K
YoY+1334.5%

Palomar Holdings, Inc. invested $416K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 1334.5% from the same quarter a year earlier.

R&D Spending

Not reported for Q2 2026.

PLMR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLMR quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$314.4M+54.7%$278.9M+59.7%$253.4M+62.7%$244.7M+64.8%$203.3M+55.1%$174.6M+47.3%$155.8M+47.8%$148.5M+63.3%
Interest Expense$4.9M+5652.3%$3.2M+3615.3%$88K+2.3%$133K+52.9%$86K-61.8%$85K-88.5%$86K-89.6%$87K-90.0%
Income Tax$17.2M+28.9%$10.5M-2.6%$16.5M+65.0%$15.7M+95.9%$13.4M+74.7%$10.8M+35.3%$10.0M+32.2%$8.0M+31.2%
Net Income$52.6M+13.0%$42.9M+0.1%$56.2M+60.6%$51.5M+68.7%$46.5M+80.8%$42.9M+62.7%$35.0M+35.0%$30.5M+65.5%
EPS (Basic)$2.00+14.9%$1.62+0.6%$2.12+59.4%$1.93+63.6%$1.74+68.9%$1.61+51.9%$1.33+27.9%$1.18+57.3%
EPS (Diluted)$1.94+15.5%$1.570.0%$2.05+58.9%$1.87+62.6%$1.68+68.0%$1.57+51.0%$1.29+25.2%$1.15+57.5%
Diluted Shares (Avg)27M-2.1%27M-0.2%N/A27M+3.7%28M+7.8%27M+7.6%N/A26M+4.9%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

PLMR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLMR quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$4.0B+40.0%$3.6B+48.9%$3.1B+34.9%$2.9B+29.3%$2.8B+40.5%$2.4B+28.7%$2.3B+32.4%$2.3B+39.9%
Cash & Equivalents$62.7M-22.9%$56.5M-52.6%$106.9M+32.9%$111.7M+29.2%$81.3M+69.9%$119.3M+94.4%$80.4M+56.1%$86.5M+63.1%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$16.1MN/A$30.5M+711.3%N/AN/AN/A$3.8M0.0%N/A
Total Liabilities$3.0B+50.3%$2.7B+62.2%$2.1B+37.5%$2.1B+31.3%$2.0B+33.8%$1.6B+18.3%$1.5B+24.0%$1.6B+30.5%
Long-Term Debt$295.8M$297.4M$0N/AN/AN/AN/AN/A
Total Equity$980.9M+15.8%$959.0M+21.3%$942.7M+29.3%$878.1M+24.9%$847.2M+59.1%$790.4M+57.6%$729.0M+54.7%$703.3M+66.9%
Retained Earnings$453.4M+28.9%$441.9M+44.8%$422.0M+60.9%$365.8M+61.0%$351.7M+78.7%$305.1M+78.4%$262.2M+81.3%$227.3M+91.2%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

PLMR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLMR quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$167.2M+38.3%$47.0M-46.1%$117.4M+61.6%$83.6M-16.6%$120.9M+119.3%$87.2M+163.2%$72.6M+226.2%$100.3M+42.0%
Stock-Based Compensation$7.4M+39.1%$8.8M+85.2%N/A$5.4M+30.7%$5.3M+34.8%$4.7M+24.2%N/A$4.1M+14.7%
Capital Expenditures$416K+1334.5%$0-100.0%$22K-55.1%$51K-73.7%$29K$35K$49K$194K+4750.0%
Free Cash Flow$166.8M+38.0%$47.0M-46.0%$117.4M+61.7%$83.6M-16.5%$120.8M+119.2%$87.1M+163.1%$72.6M+225.9%$100.1M+41.7%
Investing Cash Flow-$119.7M+25.5%-$373.4M-618.8%-$123.5M-51.9%-$17.7M+90.1%-$160.8M-460.7%-$51.9M-218.1%-$81.4M-234.5%-$179.9M-251.0%
Financing Cash Flow-$41.3M-2315.5%$276.0M+7677.4%$1.3M-52.8%-$35.5M-130.0%$1.9M+104.6%$3.5M+151.6%$2.7M+334.7%$118.2M+578.5%
Share Buybacks$41.0M$23.1M$7K$37.3M$0$0$0-100.0%$0-100.0%

Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid.

PLMR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLMR quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin16.7%-6.2pp15.4%-9.2pp22.2%-0.3pp21.0%+0.5pp22.9%+3.3pp24.6%+2.3pp22.4%-2.1pp20.5%+0.3pp
Return on Equity5.4%-0.1pp4.5%-1.0pp6.0%+1.2pp5.9%+1.5pp5.5%+0.7pp5.4%+0.2pp4.8%-0.7pp4.3%0.0pp
Return on Assets1.3%-0.3pp1.2%-0.6pp1.8%+0.3pp1.8%+0.4pp1.6%+0.4pp1.8%+0.4pp1.6%0.0pp1.3%+0.2pp
Debt-to-Equity0.30-2.0x0.31-1.8x0.00-2.1x2.35+0.1x2.34-0.4x2.07-0.7x2.10-0.5x2.24-0.6x
Asset Turnover0.080.0x0.080.0x0.080.0x0.080.0x0.070.0x0.070.0x0.070.0x0.070.0x
FCF Margin53.0%-6.4pp16.9%-33.0pp46.3%-0.3pp34.2%-33.2pp59.4%+17.4pp49.9%+21.9pp46.6%+25.5pp67.4%-10.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Palomar Holdings, Inc. PLMR FY2025 $876.0M $197.1M 22.5% $3.4B 67/100
Kemper Corporation KMPR FY2025 $4.8B $143.3M 3.0% $1.6B 8/100
Selective Insurance Group SIGI FY2025 $5.3B $466.4M 8.7% $5.1B 43/100
Mercury General Corp. MCY FY2025 $6.0B $541.1M 9.0% $5.7B 34/100
Lemonade, Inc. LMND FY2025 $737.9M -$166.0M -22.5% $3.6B 48/100
HCI Group, Inc. HCI FY2025 $900.9M $320.4M 35.6% $2.4B 61/100

Frequently Asked Questions

What is Palomar Holdings, Inc.'s annual revenue?

Palomar Holdings, Inc. (PLMR) reported $876.0M in total revenue for fiscal year 2025. This represents a 58.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Palomar Holdings, Inc.'s revenue growing?

Palomar Holdings, Inc. (PLMR) revenue grew by 58.2% year-over-year, from $553.9M to $876.0M in fiscal year 2025.

Is Palomar Holdings, Inc. profitable?

Yes, Palomar Holdings, Inc. (PLMR) reported a net income of $197.1M in fiscal year 2025, with a net profit margin of 22.5%.

Palomar Holdings, Inc. (PLMR) reported diluted earnings per share of $7.17 for fiscal year 2025. This represents a 60.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Palomar Holdings, Inc. (PLMR) had $106.9M in cash and equivalents against $0 in long-term debt.

Palomar Holdings, Inc. (PLMR) had a net profit margin of 22.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Palomar Holdings, Inc. (PLMR) has a return on equity of 20.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Palomar Holdings, Inc. (PLMR) generated $409.0M in free cash flow during fiscal year 2025. This represents a 56.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Palomar Holdings, Inc. (PLMR) generated $409.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Palomar Holdings, Inc. (PLMR) had $3.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Palomar Holdings, Inc. (PLMR) invested $137K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Palomar Holdings, Inc. (PLMR) spent $37.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Palomar Holdings, Inc. (PLMR) had 27M shares outstanding as of fiscal year 2025.

Palomar Holdings, Inc. (PLMR) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Palomar Holdings, Inc. (PLMR) had a return on assets of 6.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Palomar Holdings, Inc. (PLMR) trades at 16.9x earnings, its market capitalization divided by net income of $203.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Palomar Holdings, Inc. (PLMR) trades at 3.2x sales, its market capitalization divided by revenue of $1.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Palomar Holdings, Inc. (PLMR) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Palomar Holdings, Inc. (PLMR) has an earnings quality ratio of 2.08x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Palomar Holdings, Inc. (PLMR) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top